Last edition
News about "phase 1 trial"
Anixa Biosciences Secures Australian Patent for Breast Cancer Vaccine
Anixa Biosciences receives an Australian patent for its breast cancer vaccine technology, expanding its global intellectual property portfolio.
Phase 1 Trial | 22/09/2026 | By News Bureau
Suven Life Sciences Reports Positive Phase 1 Results for SUVN-I6107
Suven Life Sciences has reported positive topline results from the First-in-Human phase 1 study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM). The successful trial supports the advancement of SUVN-I6107 into phase 2 clinical development.
Phase 1 Trial | 16/06/2026 | By News Bureau | 216
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy